BK polyomavirus infection promotes growth and aggressiveness in bladder cancer

Virol J. 2020 Sep 14;17(1):139. doi: 10.1186/s12985-020-01399-7.

Abstract

Background: Recent studies have confirmed the integration of the BK polyomavirus (BKPyV) gene into the cellular genome of urothelial carcinomas in transplant recipients, further confirming the correlation between BKPyV and urothelial carcinomas after transplantation. However, the role BKPyV infections play in the biological function of bladder cancer remains unclear.

Methods: We developed a BKPyV-infected bladder cancer cell model and a mice tumor model to discuss the role of BKPyV infections.

Results: Our research proves that BKPyV infections promote the proliferation, invasion and migration of bladder cancer cells, while the activation of β-catenin signaling pathway is one of its mediation mechanisms.

Conclusions: We first described BKPyV infection promotes the proliferation, invasion and migration of bladder cancer. We verified the role of β-catenin signaling pathway and Epithelial-Mesenchymal Transition effect in BKPyV-infected bladder cancer. These results provide meaningful information towards the diagnosis and treatment of clinical bladder cancer.

Keywords: BK polyomavirus; Bladder cancer; Cell aggressiveness; Cell growth.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • BK Virus / pathogenicity*
  • Cell Line, Tumor
  • Cell Movement
  • Cell Proliferation
  • Cell Transformation, Neoplastic
  • Disease Models, Animal
  • Epithelial-Mesenchymal Transition
  • Humans
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Polyomavirus Infections / metabolism
  • Polyomavirus Infections / pathology*
  • Polyomavirus Infections / virology
  • Tumor Virus Infections / metabolism
  • Tumor Virus Infections / pathology*
  • Tumor Virus Infections / virology
  • Urinary Bladder Neoplasms / metabolism
  • Urinary Bladder Neoplasms / pathology*
  • Urinary Bladder Neoplasms / virology
  • Wnt Signaling Pathway
  • beta Catenin / antagonists & inhibitors
  • beta Catenin / metabolism

Substances

  • beta Catenin